ADORA2A and cancer: In these cancers, the CD73/adenosine/A2AR pathway transcriptionally upregulates CCL5 through the p38-STAT1 axis, which recruits Tregs to pancreatic tumors and promotes an immunosuppressive microenvironment via tumor-autonomous and autocrine mechanisms [121].